Patient Perspectives on Fecal Microbiota Transplantation for Clostridium Difficile Infection

Infectious Diseases and Therapy

Volumn 5, Issue 2, 2016, Pages 155-164

  Zellmer, Caroline ^a,b   De Wolfe, Travis J ^a,b   Van Hoof, Sarah ^a,b   Blakney, Rebekah ^a,b   Safdar, Nasia ^a,b  

^a WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Clostridium difficile infection; Fecal microbiota; Fecal transplant; Patient perspectives; Patient reported outcomes; Questionnaire

Indexed keywords

ABDOMINAL CRAMP; ADULT; AGED; ANTIBIOTIC THERAPY; ANXIETY ASSESSMENT; ARTICLE; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; EMOTIONAL STRESS; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; IRRITABILITY; LIKERT SCALE; MALE; MIDDLE AGED; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENCE RISK; STRUCTURED INTERVIEW; TELEPHONE INTERVIEW; VERY ELDERLY;

EID: 85006184646     PISSN: 21938229     EISSN: 21936382     Source Type: Journal    
DOI: 10.1007/s40121-016-0106-1     Document Type: Article

References (23)

1. Bartlett JG, Chang TW, Gurwith M, et al. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Eng J Med. 1978;298(10):531–4.
2. Pant CH, Sferra TJ, Deshpande A, et al. Clinical approach to severe Clostridium difficile infection: update for the hospital practitioner. Eur J Intern Med. 2011;22:561–8.
3. McFarland LV. Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol. 2008;3(5):563–78.
4. Johanesen PA, Mackin KE, Hutton ML, et al. Disruption of the Gut Microbiome: Clostridium difficile infection and the threat of antibiotic resistance. Genes (Basel). 2015;6(4):1347–60.
5. Johnson S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect. 2009;58:403–10.
6. Miller BA, Chen LF, Sexton DJ, Anderson DJ. Comparison of the burdens of hospital-onset, healthcare facility–associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol. 2011;32(4):387–90.
7. Dubberke ER, Butler AM, Reske KA, et al. Attributable outcomes of endemic Clostridium difficile—associated disease in nonsurgical patients. Emerg Infect Dis. 2008;14(7):1031–8.
8. Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis. 2012;55(suppl 2):S88–92.
9. Kwon JH, Olsen MA, Dubberke ER. The morbidity, mortality, and costs associated with Clostridium difficile infection. Infect Dis Clin North Am. 2015;29(1):123–34.
10. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol. 2013;108(4):500–8.
11. Lee CH, Belanger JE, Kassam Z, et al. The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema. Eur J Clin Microbiol Infect Dis. 2014;33(8):1425–8.
12. Almeida R, Gerbaba T, Petrof E. Recurrent Clostridium difficile infection and the microbiome. J Gastroenterol. 2016;51:1–10.
13. Gough E, Shaikh H, Manges A. Systemic review of intestinal microbial transplantation (Fecal Bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011;53(10):994–1002.
14. Brandt LJ. Editorial commentary: fecal microbiota transplantation: patient and physician attitudes. Clin Infect Dis. 2012;55(12):1659–60.
15. Zipursky JS, Sidorsky TI, Freedman CA. Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile Infection. Clin Infect Dis. 2012;55(12):1652–8.
16. Burke KE, Lamont JT. Fecal Transplant for recurrent Clostridium difficile infection in older adults: a review. J Am Geriatr Soc. 2013;61(8):1394–8.
17. Brandt LJ, Aroniadis OC, Mellow M, et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:1079–87.
18. Oldman T. Isolated cases. Nursing Times. 1998;94(11):57–9.
19. Guillemin I, Marrel A, Lambert J. Patients’ experience and perception of hospital-treated Clostridium difficile infections: a qualitative study. Patient. 2014;7(1):97–105.
20. Rao K, Safdar N. Fecal microbiota transplantation for the treatment of Clostridium difficile infection. J Hosp Med. 2016;11(1):56–61.
21. Devlin AS, Andrade CC, Carvalho D. Qualities of inpatient hospital rooms: patients’ perspectives. HERD. 2015;12(1):1–22.
22. Kahn SA, Gorawara-Bhat R, Rubin DT. Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we? Inflamm Bowel Dis. 2012;17:676–84.
23. Kahn SA, Vachon A, Rodriquez D, et al. Patient perceptions of fecal microbiota transplantation for ulcerative colitis. Inflamm Bowel Dis. 2013;19(7):1506–13.